arrow
T

Takehisa Kitazawa

Chugai Pharmaceutical Co., Ltd.
H指数:22
被引数:3,078

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137
2024-10-140
OAAI
Anti-tumor activity of orally-available cyclic peptide LUNA18 through direct RAS inhibition in RAS-altered tumors

口服可利用的环肽LUNA18在RAS改变的肿瘤中通过直接RAS抑制的抗肿瘤活性

2024-03-220
PRE
1664: Combination of LUNA18, a novel RAS inhibitor, with KRAS G12C inhibitors augments anti-tumor activity via inhibition of MAPK pathway reactivation

1664: 新型RAS抑制剂LUNA18与KRAS G12C抑制剂联合应用可通过抑制MAPK通路再激活增强抗肿瘤活性

2024-03-220
PRE
A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state

双特异性抗体NXT007在血友病A猴中发挥止血活性,足以保持非血友病状态

2024-02-0112
OAAI
Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease
2023-12-224
OAAI
A DLL3/CD3/CD137 trispecific T cell engager shows potent antitumor activity in small cell lung cancer models
2023-04-043
PRE
Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumours
2022-09-0712
OAAI